This recombinant protein is typically expressed in E. coli, yeast, or mammalian cells (e.g., HEK293) . Purification involves affinity chromatography, with tags such as Fc or His for enhanced stability and yield . Critical quality metrics include:
Activity: Functional in glycan-binding assays, validated in apoptosis and immune modulation studies .
Storage: Lyophilized or liquid formats, stable at -80°C with trehalose as a cryoprotectant .
Recombinant C. griseus Galectin-1 operates via two primary modes:
Glycan Binding: Dimerizes to crosslink LacNAc (Galβ1-4GlcNAc) residues on glycoproteins like CD4, CD45, and laminin, triggering signaling cascades .
Immunomodulation:
Dimerization Dependency: Functional activity requires stable homodimers, which can dissociate under low concentrations or oxidative conditions .
Engineering Advances: Mutagenesis (e.g., C2S substitutions) and fusion tags (Fc/His) improve stability and yield .
Therapeutic Potential: Targeting Galectin-1 in cancer or enhancing its activity in autoimmunity remains speculative due to pleiotropic effects .
KEGG: cge:100751963